FAS and fatty liver disease: The amelioration of hepatic steatosis in DIO mice expressing low levels of p63 in the liver was also consistent with the inhibition of hepatic FAS, pJNK and some of the ER stress markers such as pPERK and peIF2α/ eIF2α (Fig. 5i).